- BRCA1 is one of the most important tumour‑suppressor proteins in human biology, functioning as a master regulator of DNA repair, genome stability and cell‑cycle control. Mutations in BRCA1 dramatically increase the risk of breast, ovarian and several other cancers, underscoring its essential role in safeguarding the genome. BRCA1 operates at the heart of the DNA‑damage response, coordinating high‑fidelity repair of DNA double‑strand breaks (DSBs) through homologous recombination and integrating checkpoint signalling to prevent the propagation of genomic instability.
- BRCA1 is recruited rapidly to sites of DNA damage through interactions with the MRN complex and phosphorylated histone H2AX. Once at the break, BRCA1 forms multiple functional complexes, most notably the BRCA1–BARD1 heterodimer, which possesses E3 ubiquitin ligase activity. This enzymatic function modifies chromatin and signalling proteins, creating a permissive environment for DNA repair. BRCA1 also interacts with CtIP to promote DNA end resection, the critical first step of homologous recombination. By enabling the generation of 3′ single‑stranded DNA overhangs, BRCA1 ensures that RAD51 can be loaded efficiently to initiate strand invasion and template‑guided repair.
- BRCA1 plays a central role in determining repair pathway choice. In the presence of a sister chromatid, BRCA1 promotes homologous recombination, the most accurate form of DSB repair. When homologous recombination is not possible, BRCA1 suppresses error‑prone pathways such as non‑homologous end joining, thereby preventing chromosomal rearrangements. This ability to steer repair toward high‑fidelity pathways is one of the key mechanisms through which BRCA1 maintains genome stability and prevents oncogenic transformation.
- Beyond its direct role in DNA repair, BRCA1 is deeply integrated into cell‑cycle regulation. It participates in checkpoint activation through interactions with ATM, ATR and CHK2, ensuring that cells pause the cell cycle to allow repair. If damage is irreparable, BRCA1 contributes to signalling pathways that promote apoptosis or other forms of programmed cell death, preventing the survival of cells with dangerous genomic lesions. BRCA1 also regulates transcription, chromatin structure and centrosome duplication, linking DNA repair to broader aspects of cell physiology.
- BRCA1 is essential for maintaining replication fork stability. During replication stress, BRCA1 protects stalled forks from degradation and coordinates their restart. This function prevents replication‑associated DNA breaks, which are a major source of genomic instability in cancer cells. BRCA1 also interacts with proteins involved in the proteostasis network and the oxidative stress response, highlighting its role in integrating DNA repair with cellular stress management.
- Mutations in BRCA1 cause profound defects in homologous recombination, leading to chromosomal instability, replication stress and accumulation of DNA damage. Individuals with germline BRCA1 mutations have a markedly increased risk of breast and ovarian cancer, often at a young age. Tumours lacking functional BRCA1 exhibit “BRCAness,” a phenotype characterised by defective homologous recombination and hypersensitivity to DNA‑damaging agents. These tumours respond particularly well to PARP inhibitors, which exploit synthetic lethality by blocking alternative repair pathways that BRCA1‑deficient cells rely on for survival.
- In summary, BRCA1 is a central guardian of genome stability and a master regulator of homologous recombination. Through its roles in DNA end resection, RAD51 loading, checkpoint activation, replication fork protection and chromatin regulation, BRCA1 ensures accurate DNA repair and prevents oncogenic transformation. Its essential functions in tumour suppression make BRCA1 one of the most intensively studied proteins in molecular biology and a cornerstone of modern cancer genetics and therapeutics.
